CD274 and neoplasm: The OV stimulated an antitumor immune response in the tumor microenvironment—patients exhibited a mild dose-dependent cytokine release syndrome, increased levels of IFNα, and the proliferation of T-lymphocytes in the blood, as well as the infiltration of immune cells into the tumor and tumor PD-L1 expression.